PXD056858 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | HSP27 Functional Switch Drives Castration-Resistant Prostate Cancer via mTOR Pathway Activation, Highlighting Promising Combination Therapies to Restore Treatment Sensitivity |
| Description | Heat shock protein 27 (HSP27) is a multifunctional protein that plays pivotal roles in prostate cancer (PC) progression to a castration-resistant state, known as CRPC. In this study, we identified and analyzed HSP27-protein interaction maps across various prostatic cell models recapitulating different stages of the disease. Our results demonstrate that HSP27 undergoes a functional switch during CRPC progression by expanding its interacting protein network. Moreover, HSP27 appears to be involved in multiple crucial functions in the development of CRPC, including the regulation of the mTOR pathway. HSP27 strongly regulates mTORC1 signaling through multiple targets, including its regulatory subunit RAPTOR, while its effect on mTORC2 is comparatively moderate. It has been shown that HSP27 prevents the proteasomal degradation of RAPTOR. Combining an HSP27 inhibitor OGX-427 (Apatorsen), and mTOR inhibitors (Everolimus, Sapanisertib) demonstrated a strong synergistic anti-tumor effect in CRPC cell lines and enhanced tumor growth suppression in a xenograft model. This study provides new insights into the role of HSP27 in CRPC progression and suggests that combined therapy with an HSP27 inhibitor and mTOR inhibitors could be a promising strategy for treating CRPC. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-07-21 |
| AnnouncementXML | Submission_2026-07-21_04:33:17.389.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | AUDEBERT Stephane |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
| Instrument | Q Exactive Plus |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2024-10-16 08:52:02 | ID requested | |
| ⏵ 1 | 2026-07-21 04:33:18 | announced | |
Publication List
| 10.1186/s13046-026-03695-6; |
| Duong QH, Le TK, Tran TT, Audebert S, Camoin L, Nguyen NG, Baboudjian M, Giusiano S, Phan UTT, Zaghdoudi S, Adelaide J, Baylot V, Gleave M, Garrido C, Ta, ï, eb D, Rocchi P, HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res, 45(1):(2026) [pubmed] |
Keyword List
| submitter keyword: AP-MS, LC-MSMS, Castration Resistant Prostate Cancer (CRPC),HSP27, mTOR pathway, interactome |
Contact List
| Audebert Stéphane |
| contact affiliation | Marseille Protéomique, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France |
| contact email | stephane.audebert@inserm.fr |
| lab head | |
| AUDEBERT Stephane |
| contact affiliation | Marseille Proteomic, Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille Université U105, Institut Paoli Calmettes, 27 Boulevard Leï Roure CS30059 13273 Marseille Cedex 09 France |
| contact email | stephane.audebert@inserm.fr |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/07/PXD056858 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD056858
- Label: PRIDE project
- Name: HSP27 Functional Switch Drives Castration-Resistant Prostate Cancer via mTOR Pathway Activation, Highlighting Promising Combination Therapies to Restore Treatment Sensitivity